Fox Run Management’s Waters Corp WAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,116
Closed -$1.18M 1271
2025
Q4
$1.18M Buy
+3,116
New +$1.15M 0.18% 143
2025
Q3
Sell
-729
Closed -$254K 1267
2025
Q2
$254K Buy
+729
New +$251K 0.04% 685
2024
Q2
Sell
-659
Closed -$227K 1111
2024
Q1
$227K Buy
+659
New +$217K 0.05% 604
2023
Q2
Sell
-1,878
Closed -$581K 987
2023
Q1
$581K Sell
1,878
-460
-20% -$149K 0.19% 187
2022
Q4
$801K Buy
+2,338
New +$740K 0.32% 47
2022
Q2
Sell
-1,011
Closed -$314K 764
2022
Q1
$314K Buy
+1,011
New +$329K 0.17% 258
2021
Q3
Sell
-1,042
Closed -$360K 638
2021
Q2
$360K Buy
1,042
+240
+30% +$76K 0.33% 114
2021
Q1
$228K Buy
+802
New +$219K 0.41% 137
2019
Q4
Sell
-1,080
Closed -$241K 543
2019
Q3
$241K Buy
+1,080
New +$233K 0.22% 231
2018
Q2
Sell
-3,891
Closed -$773K 939
2018
Q1
$773K Buy
3,891
+1,178
+43% +$244K 0.19% 160
2017
Q4
$524K Buy
+2,713
New +$524K 0.15% 271
2017
Q3
Sell
-2,800
Closed -$515K 888
2017
Q2
$515K Buy
+2,800
New +$487K 0.18% 209
2016
Q4
Sell
-3,700
Closed -$586K 693
2016
Q3
$586K Buy
+3,700
New +$573K 0.35% 57

Other funds holding WAT

Fox Run Management's WAT Position: Q1 2026 in Review

Fox Run Management sold out of Waters Corp (WAT) in Q1 2026, closing a stake of 3,116 shares — an estimated $1.18M sold.

Fox Run Management first reported a position in WAT in Q3 2016 and held it in 13 quarters. The position peaked at $1.18M in Q4 2025. 1,176 funds tracked by Wall St. Rank hold WAT as of Q1 2026.

  • Fox Run Management reported no remaining Waters Corp position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 3,116 Waters Corp shares in Q1 2026, an estimated $1.18M.
  • Fox Run Management first reported a position in Waters Corp in Q3 2016 and held it in 13 quarters.
  • Fox Run Management's Waters Corp position peaked at $1.18M in Q4 2025.
  • 1,176 funds tracked by Wall St. Rank held Waters Corp as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.